DGAP-News: Novavax to Report First Quarter Financial Results on May 7, 2014

| Source: EQS Group AG
DGAP-News: Novavax, Inc. /
Novavax to Report First Quarter Financial Results on May 7, 2014

01.05.2014 / 17:51


GAITHERSBURG, Md., 2014-05-01 17:51 CEST (GLOBE NEWSWIRE) --
Novavax, Inc. (Nasdaq:NVAX) announced today that it will report its first
quarter 2014 financial results on Wednesday, May 7, 2014 after the close of the
U.S. financial markets. 

Following the earnings release, company management will host a conference call
and webcast to provide a corporate update and discuss its first quarter 2014
financial results. Details to access the conference call are as follows: 

Date:             Wednesday, May 7, 2014                                     
Time:             4:30 p.m. ET.                                              
Call-in numbers:  (877) 212-6076 (domestic) or (707) 287-9331 (international)
Webcast:          www.novavax.com, via 'Investor Info / Events' tab          

A replay of the conference call will be available from 7:30 pm on May 7, 2014
until midnight June 7, 2014. To access the replay by telephone, dial 1 (855)
859-2056 (domestic) or 1 (404) 537-3406 (international) and use passcode
34845350. The replay will also be available as a webcast and can be found on
the 'Investor Info / Events' tab on the Novavax website. 

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating novel vaccines and vaccine adjuvants to address a broad range of
infectious diseases worldwide. Using innovative proprietary recombinant protein
nanoparticle vaccine technology, the company produces vaccine candidates to
efficiently and effectively respond to both known and newly emergent diseases.
Additional information about Novavax is available on the company's website,

         CONTACT: Barclay Phillips
         SVP, Chief Financial Officer and Treasurer
         Novavax, Inc.
News Source: NASDAQ OMX

End of Corporate News


01.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language:    English        
Company:     Novavax, Inc.  
             United States  
ISIN:        US6700021040   
End of News    DGAP News-Service  
266067 01.05.2014